XENE
Xenon Pharmaceuticals Inc.
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | |
|---|---|---|---|---|---|---|---|---|---|
| Operating | |||||||||
| Operating Cash Flow | — | — | — | — | — | — | — | — | — |
| Net Income | — | — | — | — | — | — | — | — | — |
| Depreciation & Amort. | — | — | — | — | — | — | — | — | — |
| Stock-Based Comp. | — | — | — | — | — | — | — | — | — |
| Changes in WC | — | — | — | — | — | — | — | — | — |
| Investing | |||||||||
| Capital Expenditures | 799,000 | 3.1M | 5.6M | 2.9M | 2.0M | 2.6M | 1.2M | 507,000 | 315,000 |
| Acquisitions | — | — | — | — | — | — | — | — | — |
| Investing Cash Flow | — | — | — | — | — | — | — | — | — |
| Financing | |||||||||
| Debt Repayment | — | — | — | — | — | — | — | — | — |
| Common Stock Issued | — | — | — | — | — | — | — | — | — |
| Buybacks | — | — | — | — | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — | — | — | — | — |
| Financing Cash Flow | — | — | — | — | — | — | — | — | — |
| Summary | |||||||||
| Free Cash Flow | -279.9M | -184.5M | -156.7M | -103.9M | -71.6M | -50.8M | -6.0M | -35.2M | -29.0M |
| Net Change in Cash | — | — | — | — | — | — | — | — | — |